IBDEI148 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19684,1,5,0)
 ;;=5^Onychocryptosis
 ;;^UTILITY(U,$J,358.3,19684,2)
 ;;=^81221
 ;;^UTILITY(U,$J,358.3,19685,0)
 ;;=528.2^^105^1234^43
 ;;^UTILITY(U,$J,358.3,19685,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19685,1,4,0)
 ;;=4^528.2
 ;;^UTILITY(U,$J,358.3,19685,1,5,0)
 ;;=5^Oral Aphthae
 ;;^UTILITY(U,$J,358.3,19685,2)
 ;;=^114480
 ;;^UTILITY(U,$J,358.3,19686,0)
 ;;=692.72^^105^1234^44
 ;;^UTILITY(U,$J,358.3,19686,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19686,1,4,0)
 ;;=4^692.72
 ;;^UTILITY(U,$J,358.3,19686,1,5,0)
 ;;=5^Photosensitivity
 ;;^UTILITY(U,$J,358.3,19686,2)
 ;;=^93951
 ;;^UTILITY(U,$J,358.3,19687,0)
 ;;=692.6^^105^1234^46
 ;;^UTILITY(U,$J,358.3,19687,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19687,1,4,0)
 ;;=4^692.6
 ;;^UTILITY(U,$J,358.3,19687,1,5,0)
 ;;=5^Poison Ivy
 ;;^UTILITY(U,$J,358.3,19687,2)
 ;;=^271908
 ;;^UTILITY(U,$J,358.3,19688,0)
 ;;=698.0^^105^1234^62
 ;;^UTILITY(U,$J,358.3,19688,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19688,1,4,0)
 ;;=4^698.0
 ;;^UTILITY(U,$J,358.3,19688,1,5,0)
 ;;=5^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,19688,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,19689,0)
 ;;=698.9^^105^1234^61
 ;;^UTILITY(U,$J,358.3,19689,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19689,1,4,0)
 ;;=4^698.9
 ;;^UTILITY(U,$J,358.3,19689,1,5,0)
 ;;=5^Pruritic Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,19689,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,19690,0)
 ;;=696.1^^105^1234^63
 ;;^UTILITY(U,$J,358.3,19690,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19690,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,19690,1,5,0)
 ;;=5^Psoriasis
 ;;^UTILITY(U,$J,358.3,19690,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,19691,0)
 ;;=287.0^^105^1234^64
 ;;^UTILITY(U,$J,358.3,19691,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19691,1,4,0)
 ;;=4^287.0
 ;;^UTILITY(U,$J,358.3,19691,1,5,0)
 ;;=5^Purpura, Vascular
 ;;^UTILITY(U,$J,358.3,19691,2)
 ;;=^101365
 ;;^UTILITY(U,$J,358.3,19692,0)
 ;;=782.1^^105^1234^65
 ;;^UTILITY(U,$J,358.3,19692,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19692,1,4,0)
 ;;=4^782.1
 ;;^UTILITY(U,$J,358.3,19692,1,5,0)
 ;;=5^Rash NOS
 ;;^UTILITY(U,$J,358.3,19692,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,19693,0)
 ;;=706.2^^105^1234^69
 ;;^UTILITY(U,$J,358.3,19693,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19693,1,4,0)
 ;;=4^706.2
 ;;^UTILITY(U,$J,358.3,19693,1,5,0)
 ;;=5^Sebaceous Cyst
 ;;^UTILITY(U,$J,358.3,19693,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,19694,0)
 ;;=690.10^^105^1234^72
 ;;^UTILITY(U,$J,358.3,19694,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19694,1,4,0)
 ;;=4^690.10
 ;;^UTILITY(U,$J,358.3,19694,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,19694,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,19695,0)
 ;;=702.11^^105^1234^70
 ;;^UTILITY(U,$J,358.3,19695,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19695,1,4,0)
 ;;=4^702.11
 ;;^UTILITY(U,$J,358.3,19695,1,5,0)
 ;;=5^Seborrh Keratosis, Inflammatory
 ;;^UTILITY(U,$J,358.3,19695,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,19696,0)
 ;;=702.19^^105^1234^71
 ;;^UTILITY(U,$J,358.3,19696,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19696,1,4,0)
 ;;=4^702.19
 ;;^UTILITY(U,$J,358.3,19696,1,5,0)
 ;;=5^Seborrh Keratosis, Other
 ;;^UTILITY(U,$J,358.3,19696,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,19697,0)
 ;;=686.9^^105^1234^73
 ;;^UTILITY(U,$J,358.3,19697,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19697,1,4,0)
 ;;=4^686.9
 ;;^UTILITY(U,$J,358.3,19697,1,5,0)
 ;;=5^Skin Infec, Local Unsp
 ;;^UTILITY(U,$J,358.3,19697,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,19698,0)
 ;;=708.9^^105^1234^86
 ;;^UTILITY(U,$J,358.3,19698,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI148
